Oaktree Acquisition Corp. III Life Sciences (OACCU) EBIT (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly EBIT came in at -$456538.0 in Q1 2026, down 2.64% YoY from -$468910.1 in Q1 2025, and down 78.69% on a QoQ basis from -$255496.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) EBIT (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 2 years of EBIT data on file, last reported at -$456538.0 in Q1 2026.
- Quarterly EBIT fell 2.64% year-over-year to -$456538.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 million (changed N/A YoY) and the FY2025 annual result came in at -$1.2 million, down 239.87% from the prior year.
- EBIT eased to -$456538.0 in Q1 2026, from -$255496.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of -$225579.0 in Q3 2025 to a low of -$456538.0 in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -261,958.00 |
| Mar 31, 2026 | -456,538.00 |
| Dec 31, 2025 | -255,496.00 |
| Sep 30, 2025 | -225,579.00 |
| Jun 30, 2025 | -269,810.00 |
| Mar 31, 2025 | -444,802.00 |